We are live on
!
Find out more
CUAMC
China Universal Asset Management Company Portfolio holdings
AUM
$1.67B
1-Year Est. Return
89%
This Fund
S&P 500
This Quarter
Est. Return
+22.56%
1 Year Est. Return
+89%
3 Year Est. Return
+264.17%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$295M
AUM Growth
+$46.7M
(+19%)
Cap. Flow
+$5.84M
Cap. Flow
% of AUM
1.98%
Top 10 Holdings %
Top 10 Hldgs %
32.39%
Holding
456
New
65
Increased
317
Reduced
38
Closed
9
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$6.09M |
| 2 |
PayPal
PYPL
|
+$4.84M |
| 3 |
STAAR Surgical
STAA
|
+$3.72M |
| 4 |
Chipotle Mexican Grill
CMG
|
+$3.18M |
| 5 |
Microsoft
MSFT
|
+$2.94M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pinduoduo
PDD
|
+$7.85M |
| 2 |
iQIYI
IQ
|
+$7.2M |
| 3 |
ON Semiconductor
ON
|
+$4.1M |
| 4 |
Apple
AAPL
|
+$2.75M |
| 5 |
uniQure
QURE
|
+$2.39M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 38.43% |
| 2 | Consumer Discretionary | 23.55% |
| 3 | Healthcare | 18.31% |
| 4 | Communication Services | 8.83% |
| 5 | Financials | 4.58% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SYNH
151
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
| $49.8K | 0.02% |
1,399
+354
| +34% | +$12.8K |
|
152
PTC Therapeutics
PTCT
$6.06B
| $48.4K | 0.02% |
1,000
+269
| +37% | +$12.3K |
|
153
Comcast
CMCSA
$90.4B
| $48.2K | 0.02% |
+1,272
| New | +$48.1K |
|
154
CRISPR Therapeutics
CRSP
$5.22B
| $48.2K | 0.02% |
1,065
-2,533
| -70% | -$123K |
|
155
Netflix
NFLX
$309B
| $46.6K | 0.02% |
+1,350
| New | +$44.7K |
|
156
ZTO Express
ZTO
$17.6B
| $45.9K | 0.02% |
1,600
| – | – |
|
157
Cytokinetics
CYTK
$10.5B
| $45.1K | 0.02% |
1,282
+321
| +33% | +$13.1K |
|
|
ISEE
158
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| $44.8K | 0.02% |
1,843
+616
| +50% | +$13.5K |
|
159
Intellia Therapeutics
NTLA
$1.69B
| $44.4K | 0.02% |
1,192
+238
| +25% | +$9.33K |
|
160
Denali Therapeutics
DNLI
$4.04B
| $42.6K | 0.01% |
1,851
+471
| +34% | +$13K |
|
161
Legend Biotech
LEGN
$3.99B
| $42.3K | 0.01% |
878
+220
| +33% | +$10.8K |
|
|
FOLD
162
DELISTED
Amicus Therapeutics
FOLD
| $42.2K | 0.01% |
3,807
+953
| +33% | +$11.7K |
|
163
Vir Biotechnology
VIR
$1.52B
| $42.1K | 0.01% |
1,809
+456
| +34% | +$11.7K |
|
164
Acadia Pharmaceuticals
ACAD
$5.07B
| $41.4K | 0.01% |
2,198
+553
| +34% | +$10.5K |
|
165
Intel
INTC
$509B
| $40.9K | 0.01% |
+1,251
| New | +$35.4K |
|
166
Vaxcyte
PCVX
$8.88B
| $40.6K | 0.01% |
1,084
+281
| +35% | +$11.9K |
|
|
RETA
167
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
| $39.5K | 0.01% |
435
+112
| +35% | +$6.57K |
|
|
ABCM
168
DELISTED
Abcam PLC
ABCM
| $39K | 0.01% |
2,898
+2,583
| +820% | +$38.5K |
|
169
Starbucks
SBUX
$124B
| $38.9K | 0.01% |
374
+348
| +1,338% | +$36.2K |
|
170
Honeywell
HON
$74.6B
| $38.6K | 0.01% |
+214
| New | +$40.2K |
|
171
Ultragenyx Pharmaceutical
RARE
$2.65B
| $38.1K | 0.01% |
951
+239
| +34% | +$10.3K |
|
172
Intuit
INTU
$91.6B
| $37.9K | 0.01% |
+85
| New | +$34.9K |
|
173
Beam Therapeutics
BEAM
$2.76B
| $37.3K | 0.01% |
1,217
+265
| +28% | +$10.5K |
|
174
Arrowhead Research
ARWR
$12.3B
| $37.3K | 0.01% |
1,467
+390
| +36% | +$12.3K |
|
|
BPMC
175
DELISTED
Blueprint Medicines
BPMC
| $36.6K | 0.01% |
813
+205
| +34% | +$9.23K |
|
Similar funds
HA
JPM
CPO
LCI
GWM
JIP
RMC
GACM
China Universal Asset Management Company's Q1 2023 Portfolio in Review
As of Q1 2023, China Universal Asset Management Company held 456 positions worth $295M, up 19% from $249M the previous quarter. Its ten largest holdings account for 32% of the portfolio.
China Universal Asset Management Company's Q1 2023 filing shows 65 new, 317 increased, 38 reduced and 9 closed positions. Its largest new stake was Baidu: 20,500 shares worth $3.09M. The largest sale was Pinduoduo, an estimated $7.85M.
By sector, the portfolio is most concentrated in Technology at 38% of assets, up from 35% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- China Universal Asset Management Company's largest Q1 2023 buy was Baidu: 20,500 shares worth $3.09M.
- China Universal Asset Management Company added most to NVIDIA in Q1 2023, an estimated $6.09M increase.
- China Universal Asset Management Company's biggest Q1 2023 reduction was Pinduoduo, cutting an estimated $7.85M.
- China Universal Asset Management Company fully exited Tower Semiconductor in Q1 2023, selling an estimated $1.94M.
- China Universal Asset Management Company's ten largest holdings make up 32% of its $295M portfolio in Q1 2023.
- China Universal Asset Management Company opened 65 new positions and closed 9 in Q1 2023.
- China Universal Asset Management Company's portfolio value rose 19% quarter-over-quarter to $295M.
Based on China Universal Asset Management Company's 13F filing for Q1 2023, filed 28 Apr 2023.